SABBY MANAGEMENT, LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 21 filers reported holding TENAX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$19,000
-68.9%
32,842
-23.9%
0.01%
-52.9%
Q4 2019$61,000
-53.4%
43,164
-60.2%
0.02%
-41.4%
Q4 2018$131,000108,4270.03%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
GOFEN & GLOSSBERG LLC /IL/ 3,819,170$6,760,0000.16%
ARMISTICE CAPITAL, LLC 2,019,995$3,575,0000.06%
Ikarian Capital, LLC 466,261$826,0000.06%
Octagon Capital Advisors LP 30,600$54,0000.01%
FAS Wealth Partners, Inc. 58,326$103,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 46,531$82,0000.00%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 363,069$642,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders